|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1653712678 |
| 003 |
DE-627 |
| 005 |
20230428171146.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
160201s2015 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a urn:nbn:de:bsz:16-heidok-194230
|2 urn
|
| 035 |
|
|
|a (DE-627)1653712678
|
| 035 |
|
|
|a (DE-576)454862105
|
| 035 |
|
|
|a (DE-599)BSZ454862105
|
| 035 |
|
|
|a (OCoLC)944034902
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Niehr, Franziska
|d 1985-
|e VerfasserIn
|0 (DE-588)1081914491
|0 (DE-627)846788373
|0 (DE-576)45486597X
|4 aut
|
| 245 |
1 |
0 |
|a CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
|c Franziska Niehr; Wilko Weichert; Albrecht Stenzinger; Volker Budach; Ingeborg Tinhofer
|
| 264 |
|
1 |
|a London
|b BioMed Central
|c 2015
|
| 300 |
|
|
|a 1 Online-Ressource
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Aus: Journal of Translational Medicine, 13 (2015), Nr. 106. pp. 1-13. ISSN 1479-5876
|
| 700 |
1 |
|
|a Weichert, Wilko
|d 1970-2023
|e VerfasserIn
|0 (DE-588)123509106
|0 (DE-627)56134650X
|0 (DE-576)293740461
|4 aut
|
| 700 |
1 |
|
|a Stenzinger, Albrecht
|e VerfasserIn
|0 (DE-588)139606106
|0 (DE-627)703395238
|0 (DE-576)312432755
|4 aut
|
| 856 |
4 |
0 |
|u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-194230
|q application/pdf
|x Resolving-System
|z kostenfrei
|3 Volltext
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20160201
|
| 993 |
|
|
|a Article
|
| 994 |
|
|
|a 2015
|
| 998 |
|
|
|g 139606106
|a Stenzinger, Albrecht
|m 139606106:Stenzinger, Albrecht
|d 910000
|d 912000
|e 910000PS139606106
|e 912000PS139606106
|k 0/910000/
|k 1/910000/912000/
|p 3
|
| 998 |
|
|
|g 123509106
|a Weichert, Wilko
|m 123509106:Weichert, Wilko
|d 910000
|d 912000
|e 910000PW123509106
|e 912000PW123509106
|k 0/910000/
|k 1/910000/912000/
|p 2
|
| 999 |
|
|
|a KXP-PPN1653712678
|e 3367329940
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"recId":"1653712678","person":[{"display":"Niehr, Franziska","given":"Franziska","role":"aut","family":"Niehr"},{"given":"Wilko","display":"Weichert, Wilko","family":"Weichert","role":"aut"},{"role":"aut","family":"Stenzinger","given":"Albrecht","display":"Stenzinger, Albrecht"}],"note":["Aus: Journal of Translational Medicine, 13 (2015), Nr. 106. pp. 1-13. ISSN 1479-5876"],"name":{"displayForm":["Franziska Niehr; Wilko Weichert; Albrecht Stenzinger; Volker Budach; Ingeborg Tinhofer"]},"language":["eng"],"origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2015","dateIssuedKey":"2015","publisherPlace":"London"}],"title":[{"title":"CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab","title_sort":"CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab"}],"type":{"bibl":"book","media":"Online-Ressource"},"id":{"uri":["urn:nbn:de:bsz:16-heidok-194230"],"eki":["1653712678"]},"physDesc":[{"extent":"1 Online-Ressource"}]}
|
| SRT |
|
|
|a NIEHRFRANZCCI779TEMS2015
|
